Search results
Analysis | Whatever happened to Biden’s public option?
Washington Post· 7 days agoAs we ramp up for the 2024 election, I’ve wondered why talk of the public option has disappeared....
COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle -...
Benzinga· 7 days agoCanadian Biotech company Acuitas Therapeutics and Germany-based CureVac NV CVAC have settled...
Pfizer Stock Jumps On 'Massive' Upside Thanks To Paxlovid Surprise
Investor's Business Daily· 2 days agoComirnaty, the Covid vaccine Pfizer developed with BioNTech (BNTX) brought in $354 million in sales,...
Unable to work since COVID vaccination, Gatineau man pins hopes on compensation
CBC via Yahoo News· 4 days agoA Gatineau, Que., man who developed a debilitating skin ailment after receiving a COVID-19 vaccine...
The images that show the two sides of AstraZeneca’s vaccine ‘miracle’
The Telegraph via Yahoo Finance· 3 days agoJamie Scott is nothing if not a fighter. He must be to have survived a reaction to his Covid-19...
Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings
Zacks via Yahoo Finance· 4 days agoPfizer (PFE) expects its operational revenues to improve, driven by its in-line products like...
Arbutus Biopharma Corp Reports Q1 2024 Earnings: A Detailed Financial Review
GuruFocus.com via Yahoo Finance· 22 hours agoLitigation and Intellectual Property Updates Arbutus continues to defend its intellectual property vigorously, particularly in ongoing litigation with Moderna and Pfizer/BioNTech< ...
The CDC Took Out 148 Pages of Essential Information
Mercola· 11 hours agoPeople who receive a COVID-19 shot are at increased risk of myocarditis, or inflammation of the heart muscle,1 and pericarditis, which is inflammation of the outer lining of the heart. The public ...
Pfizer lifts profit forecast as CEO sees reason for optimism in 2024
Reuters via Yahoo News· 2 days ago(Reuters) -Pfizer lifted its annual earnings forecast on Wednesday and reported a first-quarter...
GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
Benzinga via Yahoo Finance· 2 days agoWednesday, GSK Plc (NYSE:GSK) reported first-quarter sales of $9.33 billion (7.4 billion Sterling...